These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 14501285)

  • 21. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
    van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
    Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
    Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
    Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes?
    Vidal-Sicart S; Pons F; Puig S; Ortega M; Vilalta A; Martín F; Rull R; Palou JM; Castel T
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):362-6. PubMed ID: 12634963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of tyrosinase mRNA in the sentinel lymph nodes of melanoma patients is not a predictor of short-term disease recurrence.
    Tatlidil C; Parkhill WS; Giacomantonio CA; Greer WL; Morris SF; Walsh NM
    Mod Pathol; 2007 Apr; 20(4):427-34. PubMed ID: 17334354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi.
    Holt JB; Sangueza OP; Levine EA; Shen P; Bergman S; Geisinger KR; Creager AJ
    Am J Clin Pathol; 2004 Jan; 121(1):58-63. PubMed ID: 14750241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological regression in primary melanoma: not a predictor of sentinel lymph node metastasis in a cohort of 397 patients.
    Socrier Y; Lauwers-Cances V; Lamant L; Garrido I; Lauwers F; Lopez R; Rochaix P; Chevreau C; Payoux P; Viraben R; Paul C; Meyer N
    Br J Dermatol; 2010 Apr; 162(4):830-4. PubMed ID: 20030641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
    Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
    Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The correlation of regression in primary melanoma with sentinel lymph node status.
    Kaur C; Thomas RJ; Desai N; Green MA; Lovell D; Powell BW; Cook MG
    J Clin Pathol; 2008 Mar; 61(3):297-300. PubMed ID: 17675538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between tumor-infiltrating lymphocytes and sentinel lymph node positivity in thin melanoma.
    Santos FMD; Silva FCD; Pedron J; Furian RD; Fortes C; Bonamigo RR
    An Bras Dermatol; 2019; 94(1):47-51. PubMed ID: 30726463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Wong SL; Faries MB; Kennedy EB; Agarwala SS; Akhurst TJ; Ariyan C; Balch CM; Berman BS; Cochran A; Delman KA; Gorman M; Kirkwood JM; Moncrieff MD; Zager JS; Lyman GH
    J Clin Oncol; 2018 Feb; 36(4):399-413. PubMed ID: 29232171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma.
    Tejera-Vaquerizo A; Nagore E; Puig S; Robert C; Saiag P; Martín-Cuevas P; Gallego E; Herrera-Acosta E; Aguilera J; Malvehy J; Carrera C; Cavalcanti A; Rull R; Vilalta-Solsona A; Lannoy E; Boutros C; Benannoune N; Tomasic G; Aegerte P; Vidal-Sicart S; Palou J; Alos LL; Requena C; Traves V; Pla Á; Bolumar I; Soriano V; Guillén C; Herrera-Ceballos E
    Eur J Cancer; 2015 Sep; 51(13):1780-93. PubMed ID: 26072362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective multicenter evaluation of cutaneous melanomas in Turkey.
    Gamsizkan M; Yilmaz I; Buyukbabani N; Demirkesen C; Demiriz M; Cetin ED; Ince U; Akalin T; Demirkan NC; Lebe B; Erdem O; Gokoz O; Sakiz D; Demireli PT; Astarci HM; Adim SB; Zemheri IE; Acikalin A; Yaman B; Aydin O; Bassorgun CI
    Asian Pac J Cancer Prev; 2014; 15(23):10451-6. PubMed ID: 25556491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
    Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
    J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin.
    Blaheta HJ; Schittek B; Breuninger H; Sotlar K; Ellwanger U; Thelen MH; Maczey E; Rassner G; Bueltmann B; Garbe C
    Am J Surg Pathol; 1999 Jul; 23(7):822-8. PubMed ID: 10403306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
    Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS
    Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma.
    Mariani G; Gipponi M; Moresco L; Villa G; Bartolomei M; Mazzarol G; Bagnara MC; Romanini A; Cafiero F; Paganelli G; Strauss HW
    J Nucl Med; 2002 Jun; 43(6):811-27. PubMed ID: 12050328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.